<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Laxmi Dental Ltd. (LAXMIDENTL) — Tipsheet</title>
    <link>https://tipsheet.markets/company/laxmidentl/</link>
    <atom:link href="https://tipsheet.markets/company/laxmidentl/feed.xml" rel="self" type="application/rss+xml" />
    <description>Every Tipsheet Editorial note covering Laxmi Dental Ltd. (LAXMIDENTL), newest first. Grounded in BSE/NSE primary-source filings.</description>
    <language>en-in</language>
    <lastBuildDate>Fri, 10 Jul 2026 16:37:11 GMT</lastBuildDate>
    <item>
      <title>Laxmi Dental record revenue, but no new margin target for FY27</title>
      <link>https://tipsheet.markets/laxmidentl-laxmi-dental-record-revenue-but-no-new-margin-target-for-fy27-104158/</link>
      <guid isPermaLink="true">https://tipsheet.markets/laxmidentl-laxmi-dental-record-revenue-but-no-new-margin-target-for-fy27-104158/</guid>
      <pubDate>Sat, 30 May 2026 15:18:17 GMT</pubDate>
      <description>Management walked back its 18-20% EBITDA margin guidance, citing a tougher domestic market. The stock must now price in lower profitability.</description>
      <content:encoded><![CDATA[<p><em>Management walked back its 18-20% EBITDA margin guidance, citing a tougher domestic market. The stock must now price in lower profitability.</em></p>
<h3>What’s new</h3><ul><li>Record Q4 revenue of ₹74 cr, driven by a rebound in the international lab business.</li><li>US import tariffs fell from 50% to 10%, a key driver for the international segment.</li><li>Management withdrew the prior FY27 guidance for 18-20% EBITDA margins.</li></ul>
<h3>Why it matters</h3><p>A record top line paired with a guidance pullback is a classic signal of shifting profitability dynamics. Laxmi’s domestic aligner business faces stiffer competition, and management won’t promise the margins it did three months ago. That forces a reset in analyst models for FY27 earnings.</p>
<h3>What we’re watching</h3><ul><li>Whether management offers a new, lower margin range in the coming quarters.</li><li>Early traction for the iScope 360 subscription platform.</li><li>The sustainability of international lab growth as tariff tailwinds normalize.</li></ul>
<h3>The full read</h3><p>Laxmi Dental posted record quarterly revenue of <strong>₹74 crore</strong> in Q4 FY26. The top line was lifted by a recovering international lab business after the US slashed import tariffs from <strong>50%</strong> to <strong>10%</strong>. The good news stops there. On the earnings call, management walked back its prior FY27 guidance for <strong>18-20%</strong> EBITDA margins. The reason given was a mix of macro uncertainty and a tougher fight for share in the Indian aligner market. The company also launched iScope 360, an AI-connected platform for remote dental monitoring, but that is a longer-term story. The immediate takeaway is a guidance reset. Laxmi’s record quarter is real, but its promise of steady profit growth is now off the table.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=544339&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=LAXMIDENTL">NSE</a></p>]]></content:encoded>
      <category>Earnings</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>Laxmi Dental hits record revenue, then pulls FY27 guidance</title>
      <link>https://tipsheet.markets/laxmidentl-laxmi-dental-hits-record-revenue-then-pulls-fy27-guidance-95060/</link>
      <guid isPermaLink="true">https://tipsheet.markets/laxmidentl-laxmi-dental-hits-record-revenue-then-pulls-fy27-guidance-95060/</guid>
      <pubDate>Fri, 22 May 2026 11:04:24 GMT</pubDate>
      <description>A strong Q4 was immediately overshadowed by management&#39;s refusal to reaffirm profit targets, after missing FY26 margin guidance.</description>
      <content:encoded><![CDATA[<p><em>A strong Q4 was immediately overshadowed by management's refusal to reaffirm profit targets, after missing FY26 margin guidance.</em></p>
<h3>What’s new</h3><ul><li>Record Q4 revenue of ₹74 cr and EBITDA margin of 18.3%.</li><li>Management refused to reaffirm FY27 EBITDA (18-20%) and PAT margin (13-15%) targets, citing macro uncertainty.</li><li>FY26 PAT margin of 10.4% fell short of the 13-15% guidance given in prior calls.</li></ul>
<h3>Why it matters</h3><p>A record quarter is immediately overshadowed by a guidance retreat. Management missed its own FY26 profit target, then refused to commit to FY27 numbers. That sequence erodes credibility more than a single earnings miss would.</p>
<h3>What we’re watching</h3><ul><li>Whether management reissues guidance in the Q1 FY27 call.</li><li>Impact of US tariff normalization from 50% to 10% on export margins.</li><li>Adoption ramp for the new iScope 360 remote dentistry platform.</li></ul>
<h3>The full read</h3><p>Laxmi Dental's Q4 was its best ever: <strong>₹74 cr</strong> revenue, <strong>18.3%</strong> EBITDA margin. The quarter also brought US tariff relief, from <strong>50%</strong> to <strong>10%</strong>, and the launch of the iScope 360 platform. The numbers are good. The guidance is not. Management refused to reaffirm FY27 targets. They walked back the previously stated EBITDA margin of <strong>18-20%</strong> and PAT margin of <strong>13-15%</strong>, citing macro uncertainty. This comes after a FY26 PAT margin of <strong>10.4%</strong> – well below the <strong>13-15%</strong> band flagged earlier. A record quarter doesn't fix a guidance miss. The open question is how long management stays silent. A single quarter of outperformance, followed by a guidance retreat, forces a recalibration of trust.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=544339&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=LAXMIDENTL">NSE</a></p>]]></content:encoded>
      <category>Concalls</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>Laxmi Dental re-announces audited Q4 and FY26 results it already filed.</title>
      <link>https://tipsheet.markets/laxmidentl-laxmi-dental-re-announces-audited-q4-and-fy26-results-it-already-filed-94993/</link>
      <guid isPermaLink="true">https://tipsheet.markets/laxmidentl-laxmi-dental-re-announces-audited-q4-and-fy26-results-it-already-filed-94993/</guid>
      <pubDate>Fri, 22 May 2026 00:25:31 GMT</pubDate>
      <description>A routine press release adds management narrative to numbers that are already public. The event was the earlier filing.</description>
      <content:encoded><![CDATA[<p><em>A routine press release adds management narrative to numbers that are already public. The event was the earlier filing.</em></p>
<h3>What’s new</h3><ul><li>Laxmi Dental issued a press release with its audited Q4 and FY26 consolidated results.</li><li>The core numbers were already disclosed in a prior audited filing to the exchanges.</li><li>This release adds management commentary but no revised financial figures.</li></ul>
<h3>Why it matters</h3><p>This is a dissemination format, not an event. The material data was released earlier. For a micro-cap, the only new element is the narrative wrapper, which carries no incremental financial information.</p>
<h3>What we’re watching</h3><ul><li>The next quarterly filing, which will be the first source of new operational data.</li><li>Whether a concall adds context to the highest-ever quarterly revenue claim.</li><li>Any stock reaction to a release containing zero new financial information.</li></ul>
<h3>The full read</h3><p>Laxmi Dental filed a press release with its audited Q4 and FY26 results. The numbers are already public. This is a standard dissemination wrapper for a micro-cap, not a new disclosure. The earlier audited results were the event. The score is <strong>5/10</strong>. For investors tracking the stock, this changes nothing. The next data point is the next quarter. Hardly a catalyst.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=544339&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=LAXMIDENTL">NSE</a></p>]]></content:encoded>
      <category>Earnings</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
    <item>
      <title>Laxmi Dental posts 22% revenue growth, but a new labour-law charge hits profit</title>
      <link>https://tipsheet.markets/laxmidentl-laxmi-dental-posts-22-revenue-growth-but-a-new-labour-law-charge-hits-profit-94943/</link>
      <guid isPermaLink="true">https://tipsheet.markets/laxmidentl-laxmi-dental-posts-22-revenue-growth-but-a-new-labour-law-charge-hits-profit-94943/</guid>
      <pubDate>Thu, 21 May 2026 22:19:46 GMT</pubDate>
      <description>Standalone profit fell after a ₹51.6 cr exceptional charge for gratuity costs. Revenue and underlying profit both grew strongly.</description>
      <content:encoded><![CDATA[<p><em>Standalone profit fell after a ₹51.6 cr exceptional charge for gratuity costs. Revenue and underlying profit both grew strongly.</em></p>
<h3>What’s new</h3><ul><li>Standalone annual revenue grew 21.8% to ₹2,060 million; profit before exceptional items rose 50.8% to ₹261 million.</li><li>A ₹51.6 million exceptional charge for new labour-code gratuity costs pulled standalone PBT down to ₹209.7 million.</li><li>Consolidated revenue grew 14.8% to ₹2,715 million; an auditor gave an unmodified opinion.</li></ul>
<h3>Why it matters</h3><p>The underlying business is growing, but a new regulatory cost is now on the books. The charge is one-time, but it compresses headline profit and may repeat for other firms as the labour codes are implemented across sectors.</p>
<h3>What we’re watching</h3><ul><li>Whether the gratuity charge is truly one-off or if further past-service costs emerge.</li><li>The company's capital allocation now that the P&amp;L is cleaner.</li><li>Consolidated profit growth lagging standalone, suggesting subsidiary drag.</li></ul>
<h3>The full read</h3><p>Laxmi Dental's core business is growing. Standalone revenue rose <strong>21.8%</strong> to <strong>₹2,060 million</strong>, and underlying profit jumped <strong>50.8%</strong> to <strong>₹261 million</strong>. But the headline profit tells a different story. A one-time <strong>₹51.6 million</strong> charge for past gratuity costs under new labour codes pulled profit before tax down to <strong>₹209.7 million</strong>, erasing the underlying gains and falling short of last year's <strong>₹243.5 million</strong>. The consolidated picture is similar, with revenue up <strong>14.8%</strong> to <strong>₹2,715 million</strong> but profit growth held back by a <strong>₹57.8 million</strong> exceptional item. The auditor signed off with an unmodified opinion, so the numbers themselves aren't in dispute. The question now is how widespread these labour-code charges will become across the sector.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=544339&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=LAXMIDENTL">NSE</a></p>]]></content:encoded>
      <category>Earnings</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
  </channel>
</rss>